Role of PLCgamma and Ca(2+) in VEGF- and FGF-induced choroidal endothelial cell proliferation.
Although both vascular endothelial growth factor (VEGF) and fibroblast growth factor (FGF) receptors have been shown to be important in the regulation of vascular endothelial cell growth, the roles of phospholipase C (PLC)gamma and Ca(2+) in their downstream signaling cascades are still not clear. We have examined the effects of VEGF and FGF on PLCgamma phosphorylation and on changes in intracellular Ca(2+) levels in primary endothelial cells. VEGF stimulation leads to PLCgamma activation and increases in intracellular Ca(2+), which are correlated with mitogen-activated protein (MAP) kinase (MAPK) activation and cell growth. Inhibition of Ca(2+) increases by the Ca(2+) chelator 1,2-bis(2-aminophenoxy) ethane-N,N,N',N'-tetraacetic acid (BAPTA)-AM resulted in marked inhibition of MAPK activation, which was shown to be linked to regulation of cell growth in these cells. In contrast, FGF stimulation did not lead to PLCgamma activation or to changes in intracellular Ca(2+) levels, although MAPK phosphorylation and stimulation of cell proliferation were observed. Neither BAPTA-AM nor the PLC inhibitor U-73122 had an effect on these FGF-stimulated responses. These data demonstrate a direct role for PLCgamma and Ca(2+) in VEGF-regulated endothelial cell growth, whereas this signaling pathway is not linked to FGF-mediated effects in primary endothelial cells. Thus endothelial cell-specific factors regulate the ability of VEGF receptors and FGF receptors to couple to this signaling pathway.
McLaughlin
A P
AP
Department of Biological Sciences, Allergan, Incorporated, Irvine, California 92612, USA.
De Vries
G W
GW
D000911:Antibodies, Monoclonal; D015153:Blotting, Western; D002118:Calcium / Q000502:physiology*; D002455:Cell Division / Q000502:physiology; D002831:Choroid Plexus / Q000166:cytology; D004247:DNA / Q000096:biosynthesis; D016228:Endothelial Growth Factors / Q000502:physiology*; D004730:Endothelium, Vascular / Q000166:cytology*; D004963:Estrenes / Q000494:pharmacology; D005346:Fibroblast Growth Factors / Q000502:physiology*; D006801:Humans; D007527:Isoenzymes / Q000502:physiology*; D008222:Lymphokines / Q000502:physiology*; D051966:Phospholipase C gamma; D010766:Phosphorylation; D011233:Precipitin Tests; D011760:Pyrrolidinones / Q000494:pharmacology; D011994:Recombinant Proteins / Q000494:pharmacology; D010738:Type C Phospholipases / Q000037:antagonists & inhibitors / Q000502:physiology*; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors
D000911:Antibodies, Monoclonal; D016228:Endothelial Growth Factors; D004963:Estrenes; D007527:Isoenzymes; D008222:Lymphokines; D011760:Pyrrolidinones; D011994:Recombinant Proteins; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors; C060229:1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione; D005346:Fibroblast Growth Factors; D004247:DNA; D010738:Type C Phospholipases; D051966:Phospholipase C gamma; D002118:Calcium